Sotagliflozin (LX-4211) is a SGLT2/1 Inhibitor for Type 2 Diabetes Research
In this article, we will introduce a potent and orally available SGLT2/1 Inhibitor, Sotagliflozin (LX-4211). It exhibits IC50 values of 0.0018 µΜ and 0.036 µM for SGLT-2 and SGLT-1, respectively. Sotagliflozin's…